AN INVESTIGATOR INITIATED STUDY TO OBSERVE AND EVALUATE THE INCIDENCE OF EGFR MUTATIONS IN ADULT INDIAN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Not Applicable
- Conditions
- Health Condition 1: null- Non-small cell lung Cancer
- Registration Number
- CTRI/2012/05/002665
- Lead Sponsor
- Dr Senthil Rajappa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1.Subjects with non-small cell lung Cancer.
2.Subjects of Physicians who are willing to share their subjectsâ?? data for this study.
3.Ethics Committeeâ??s permission to conduct the analysis on a retrospective manner without the physical consent of the subjects who have contributed to the existing data from their respective institutions
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of EGFR mutationsTimepoint: 10 Months
- Secondary Outcome Measures
Name Time Method ï??Types of mutations - incorrelation with demography, clinical parameters, etc. of the following: <br/ ><br> <br/ ><br>â?¢% of Exon 19 Deletions <br/ ><br>â?¢% of EGFR L858R (Exon 21) mutations <br/ ><br>â?¢% of EGFR T790M (Exon 20) mutations <br/ ><br>â?¢% of EGFR L861Q (Exon 21) mutations <br/ ><br>â?¢% of EGFR G719X (Exon 18) mutations <br/ ><br>â?¢% of EGFR S7681 (Exon 20) mutations <br/ ><br>â?¢% of Exon 20 Insertions <br/ ><br>Timepoint: After Ten Months <br/ ><br>